NCT02264171View on ClinicalTrials.gov

Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

April 30, 2008

Primary Completion Date

June 30, 2008

Conditions
Healthy
Interventions
DRUG

Tamsulosin HCl

DRUG

Ketoconazole

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02264171 - Study to Investigate the Effect of Ketoconazole Mediated CYP3A4 Inhibition on Pharmacokinetics of Tamsulosin in Healthy Male Volunteers | Biotech Hunter | Biotech Hunter